Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids in elderly patients with mild or moderate COVID-19
NCT05855395Unknown
- Sponsor
- Huashan Hospital
- Start
- May 2023
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Proportion of patients who progress to severe or critical COVID-19 within 28 days. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05855395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855395.